Resources
Next-Level Eye Comfort: Expert Guides and RXOLVE® Insights for Lasting Relief
Key findings
67% reduction in SCORAD index vs. 34% with standard care (p<0.001)
Journal of Clinical Dermatology, 2024
Key findings
67% reduction in SCORAD index vs. 34% with standard care (p<0.001)
Journal of Clinical Dermatology, 2024